Numerai’s Encompass Health EHC Stock Holding History

Numerai’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.42M	Buy	35,335 +19,204	+119%	+$1.97M	0.34%	60
2025 Q4	$1.71M	Buy	+16,131	New	+$1.87M	0.21%	150

Other funds holding EHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Numerai's EHC Position: Q1 2026 in Review

Numerai increased its Encompass Health (EHC) stake by 119% in Q1 2026, buying an estimated $1.97M and bringing the position to 35,335 shares worth $3.42M. The position accounts for 0.34% of the portfolio, ranked #60.

Numerai first reported a position in EHC in Q4 2025 and has held it in 2 quarters since. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

Numerai held 35,335 shares of Encompass Health worth $3.42M as of Q1 2026.
Numerai bought 19,204 Encompass Health shares in Q1 2026, an estimated $1.97M.
Encompass Health made up 0.34% of Numerai's portfolio in Q1 2026, its #60 holding.
Numerai first reported a position in Encompass Health in Q4 2025 and has held it in 2 quarters since.
577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Numerai's 13F filing for Q1 2026, filed 15 May 2026.